FMA
LABU icon

FNY Managed Accounts’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

FNY Managed Accounts’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-500
Closed -$274K – 360
2016
Q1 		$274K Buy
+500
New +$316K 0.48% 50

Other funds holding LABU

HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FNY Managed Accounts's LABU Position: Q2 2016 in Review

FNY Managed Accounts sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2016, closing a stake of 500 shares — an estimated $274K sold.

FNY Managed Accounts first reported a position in LABU in Q1 2016 and held it in 1 quarter. The position peaked at $274K in Q1 2016. 19 funds tracked by Wall St. Rank hold LABU as of Q2 2016.

  • FNY Managed Accounts reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2016 after selling out during the quarter.
  • FNY Managed Accounts sold 500 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2016, an estimated $274K.
  • FNY Managed Accounts first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2016 and held it in 1 quarter.
  • FNY Managed Accounts's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $274K in Q1 2016.
  • 19 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2016.

Based on FNY Managed Accounts's 13F filing for Q2 2016, filed 27 Jul 2016.